Presence of apolipoprotein E ϵ4 allele predisposes to early onset of primary Sjögren's syndrome

BACKGROUND: Apolipoprotein E (apoE) polymorphism plays a central role in lipid metabolism, but has recently also been suggested to regulate inflammation, as judged by levels of serum C-reactive protein (CRP). OBJECTIVE: To establish whether polymorphism of the apoE genes affects susceptibility to primary Sjogren's syndrome (pSS), degree of inflammation or age of onset of pSS. METHODS: ApoE genotype distribution and allelic frequencies were analysed using PCR and the TaqMan system in 63 Finnish Caucasian patients with pSS and in 64 healthy controls matched for sex, ethnic origin and area of residence. The clinical and immunological data on the pSS patients were analysed in relation to the apoE genotypes. RESULTS: There was no difference between pSS patients and controls in apoE genotype and allelic frequencies. The apoE epsilon4 allele was significantly associated with early onset of pSS in the entire population and in female patients (Kaplan-Meier log rank test, P = 0.0407 and P = 0.0168, respectively). The average age (+/- S.D.) of onset of pSS in all apoE epsilon4 allele carriers was 46 +/- 12 and in other genotypes it was 53 +/- 10 yr (P = 0.031, t-test). ApoE polymorphism was not associated with signs of inflammation evaluated by such markers as concentration of plasma CRP, plasma interleukin-6, plasma TNF-alpha, immunoglobulin G and haemoglobin, or leucocyte count or ESR. CONCLUSIONS: ApoE polymorphism does not affect susceptibility to pSS or levels of plasma inflammatory indices in patients with pSS. However, a clear association prevails between apoE epsilon4 and early onset of pSS.

[1]  R. Mahley,et al.  Apolipoprotein E: far more than a lipid transport protein. , 2000, Annual review of genomics and human genetics.

[2]  S. Gauthier,et al.  Apolipoprotein E polymorphism and Alzheimer's disease , 1993, The Lancet.

[3]  R. Fox,et al.  Sjögren's syndrome , 1995, The Lancet.

[4]  T. Lehtimäki,et al.  Age-dependent association of apolipoprotein E genotype with coronary and aortic atherosclerosis in middle-aged men: an autopsy study. , 1999, Circulation.

[5]  A. Pfeufer,et al.  TaqMan Systems for Genotyping of Disease-Related Polymorphisms Present in the Gene Encoding Apolipoprotein E , 2002, Clinical chemistry and laboratory medicine.

[6]  R. Jonsson,et al.  Recent advances in understanding molecular mechanisms in the pathogenesis and antibody profile of Sjögren’s syndrome , 2003, Current rheumatology reports.

[7]  A. Hill,et al.  Common apolipoprotein E polymorphisms and risk of clinical malaria in the Gambia , 2004, Journal of Medical Genetics.

[8]  A. Pasternack,et al.  The occurrence of renal involvement in primary Sjögren's syndrome: a study of 78 patients. , 1999, Rheumatology.

[9]  C. Robinson,et al.  Sjögren's syndrome. Proposed criteria for classification. , 1986, Arthritis and rheumatism.

[10]  A. Pasternack,et al.  Elevated interleukin-6 plasma levels are regulated by the promoter region polymorphism of the IL6 gene in primary Sjögren's syndrome and correlate with the clinical manifestations of the disease. , 2001, Rheumatology.

[11]  G. Hughes,et al.  Serum C-reactive protein in primary Sjögren's syndrome. , 1983, Clinical and experimental rheumatology.

[12]  E. Faragher,et al.  Does apolipoprotein E polymorphism influence susceptibility to malaria? , 2003, Journal of medical genetics.

[13]  D. Chisholm,et al.  Labial salivary gland biopsy in Sjögren's disease , 1968, Journal of clinical pathology.

[14]  R. Jonsson,et al.  Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group , 2002, Annals of the rheumatic diseases.

[15]  M. Hill,et al.  Apolipoprotein E gene determines serum testosterone and dehydroepiandrosterone levels in postmenopausal women. , 2002, European journal of endocrinology.

[16]  C. Ehnholm,et al.  Apolipoprotein E polymorphism and C-reactive protein in dyslipidemic middle-aged men. , 2001, Atherosclerosis.

[17]  J. Lambert,et al.  The allelic modulation of apolipoprotein E expression by oestrogen: potential relevance for Alzheimer’s disease , 2004, Journal of Medical Genetics.